Guanqing Wu

5.7k total citations · 1 hit paper
45 papers, 4.3k citations indexed

About

Guanqing Wu is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Guanqing Wu has authored 45 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 35 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Guanqing Wu's work include Genetic and Kidney Cyst Diseases (34 papers), Renal and related cancers (26 papers) and Genetic Syndromes and Imprinting (15 papers). Guanqing Wu is often cited by papers focused on Genetic and Kidney Cyst Diseases (34 papers), Renal and related cancers (26 papers) and Genetic Syndromes and Imprinting (15 papers). Guanqing Wu collaborates with scholars based in United States, China and Canada. Guanqing Wu's co-authors include Stefan Somlo, Yiqiang Cai, David M. Reynolds, Tomohito Hayashi, Toshio Mochizuki, Jong Hoon Park, Yoshiko Maeda, Martijn H. Breuning, Barbera Veldhuisen and Dorien J.M. Peters and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Guanqing Wu

44 papers receiving 4.3k citations

Hit Papers

PKD2 , a Gene for Polyc... 1996 2026 2006 2016 1996 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanqing Wu United States 28 3.1k 3.0k 1.0k 478 317 45 4.3k
Alessandra Boletta Italy 33 3.4k 1.1× 3.2k 1.1× 1.2k 1.2× 531 1.1× 311 1.0× 73 4.5k
Terry Watnick United States 41 4.2k 1.3× 3.5k 1.2× 1.1k 1.1× 374 0.8× 594 1.9× 78 5.3k
Oxana Ibraghimov‐Beskrovnaya United States 29 2.0k 0.6× 3.7k 1.2× 624 0.6× 795 1.7× 221 0.7× 43 4.6k
Yoshiko Maeda Japan 18 1.3k 0.4× 1.4k 0.5× 586 0.6× 216 0.5× 216 0.7× 41 2.5k
Marjo Kestilä Finland 23 1.2k 0.4× 2.7k 0.9× 510 0.5× 277 0.6× 274 0.9× 48 4.8k
Matias Simons Germany 25 1.1k 0.3× 2.4k 0.8× 235 0.2× 705 1.5× 147 0.5× 39 3.5k
Yoav Segal United States 22 845 0.3× 1.1k 0.4× 371 0.4× 200 0.4× 121 0.4× 40 1.9k
Monique Losekoot Netherlands 34 1.3k 0.4× 1.4k 0.4× 349 0.3× 135 0.3× 125 0.4× 125 3.1k
Takanori Muto Japan 13 1.3k 0.4× 1.8k 0.6× 713 0.7× 108 0.2× 394 1.2× 16 4.1k
Gregory M. Landes United States 26 1.0k 0.3× 2.5k 0.8× 194 0.2× 147 0.3× 117 0.4× 35 3.3k

Countries citing papers authored by Guanqing Wu

Since Specialization
Citations

This map shows the geographic impact of Guanqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanqing Wu more than expected).

Fields of papers citing papers by Guanqing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanqing Wu. The network helps show where Guanqing Wu may publish in the future.

Co-authorship network of co-authors of Guanqing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guanqing Wu. A scholar is included among the top collaborators of Guanqing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanqing Wu. Guanqing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Meng, Jialin, et al.. (2018). Construction of human PKD2 lentivirus to rectify polycystin-2 expression and Wnt/β-catenin signaling pathways in the Pkd2-null cell lines. Zhonghua miniao waike zazhi. 39(1). 62–68. 1 indexed citations
3.
Li, Ao, Song Fan, Jialin Meng, et al.. (2018). Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD. JCI Insight. 3(5). 32 indexed citations
4.
Zhou, Hui, Guanqing Wu, Xueyou Ma, et al.. (2018). Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways. Journal of Experimental & Clinical Cancer Research. 37(1). 89–89. 31 indexed citations
5.
Kaimori, Jun-Ya, Patricia Outeda, Miguel A. García-González, et al.. (2017). NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology. Scientific Reports. 7(1). 7733–7733. 18 indexed citations
6.
Li, Ao, Song Fan, Jialin Meng, et al.. (2017). Rapamycin treatment dose‐dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell‐cycle‐associated CDK1/cyclin axis. Journal of Cellular and Molecular Medicine. 21(8). 1619–1635. 37 indexed citations
7.
Ma, Xueyou, Kun Tang, Chunguang Yang, et al.. (2016). Bladder neck preservation improves time to continence after radical prostatectomy: a systematic review and meta-analysis. Oncotarget. 7(41). 67463–67475. 51 indexed citations
8.
Li, Ao, Xin Tian, Xiaoli Zhang, et al.. (2015). Human Polycystin-2 Transgene Dose-Dependently Rescues ADPKD Phenotypes in Pkd2 Mutant Mice. American Journal Of Pathology. 185(10). 2843–2860. 15 indexed citations
9.
Kim, Ingyu, Yulong Fu, Kwokyin Hui, et al.. (2008). Fibrocystin/Polyductin Modulates Renal Tubular Formation by Regulating Polycystin-2 Expression and Function. Journal of the American Society of Nephrology. 19(3). 455–468. 95 indexed citations
10.
Wu, Yuliang, Xiao‐Qing Dai, Qiang Li, et al.. (2006). Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Human Molecular Genetics. 15(22). 3280–3292. 94 indexed citations
11.
Mai, Weiyi, Dong Chen, Tianbing Ding, et al.. (2005). Inhibition ofPkhd1Impairs Tubulomorphogenesis of Cultured IMCD Cells. Molecular Biology of the Cell. 16(9). 4398–4409. 59 indexed citations
12.
Li, Qiang, Yue Dai, Lei Guo, et al.. (2003). Polycystin-2 Associates with Tropomyosin-1, an Actin Microfilament Component. Journal of Molecular Biology. 325(5). 949–962. 66 indexed citations
13.
Li, Zhong, Michael Hannigan, Zhicheng Mo, et al.. (2003). Directional Sensing Requires Gβγ-Mediated PAK1 and PIXα-Dependent Activation of Cdc42. Cell. 114(2). 215–227. 322 indexed citations
14.
Wu, Guanqing. (2002). Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Human Molecular Genetics. 11(16). 1845–1854. 104 indexed citations
15.
Xiong, Huaqi, Yongxiong Chen, Yajun Yi, et al.. (2002). A Novel Gene Encoding a TIG Multiple Domain Protein Is a Positional Candidate for Autosomal Recessive Polycystic Kidney Disease. Genomics. 80(1). 96–104. 52 indexed citations
16.
Wu, Guanqing, Glen S. Markowitz, Li Li, et al.. (2000). Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nature Genetics. 24(1). 75–78. 300 indexed citations
17.
Park, Jong Hoon, Li Li, Yiqiang Cai, et al.. (2000). Cloning and Characterization of the Murine Pkd2 Promoter. Genomics. 66(3). 305–312. 7 indexed citations
18.
Reynolds, David M., Tomohito Hayashi, Yiqiang Cai, et al.. (1999). Aberrant Splicing in the PKD2 Gene as a Cause of Polycystic Kidney Disease. Journal of the American Society of Nephrology. 10(11). 2342–2351. 72 indexed citations
19.
Lens, Xosé M., Luiz F. Onuchic, Guanqing Wu, et al.. (1997). An Integrated Genetic and Physical Map of the Autosomal Recessive Polycystic Kidney Disease Region. Genomics. 41(3). 463–466. 21 indexed citations
20.
Wu, Guanqing, Toshio Mochizuki, Thanh C. Le, et al.. (1997). Molecular Cloning, cDNA Sequence Analysis, and Chromosomal Localization of MousePkd2. Genomics. 45(1). 220–223. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026